Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC. | Respir Med;97 Suppl D: S20-8, 2003 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC.

Vastagh, E; Kuna, P; Calistruc, P; Bogdan, M A.

Affiliation

Vastagh E; Sote Tùdogyogyszati Klinica, Budapest, Hungary.

Respir Med ; 97 Suppl D: S20-8, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14753248

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Budesonide Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Respir Med Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Anti-Asthmatic Agents / Budesonide Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Respir Med Year: 2003 Document type: Article Affiliation country: Country of publication: